- Home
- CMCO vs RAPT Comparison
CMCO vs RAPT Comparison
Compare CMCO & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCO
- RAPT
- Stock Information
- Founded
- CMCO 1875
- RAPT 2015
- Country
- CMCO United States
- RAPT United States
- Employees
- CMCO N/A
- RAPT N/A
- Industry
- CMCO Construction/Ag Equipment/Trucks
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- CMCO Industrials
- RAPT Health Care
- Exchange
- CMCO Nasdaq
- RAPT Nasdaq
- Market Cap
- CMCO 430.3M
- RAPT 498.4M
- IPO Year
- CMCO 1996
- RAPT 2019
- Fundamental
- Price
- CMCO $15.00
- RAPT $29.70
- Analyst Decision
- CMCO Hold
- RAPT Strong Buy
- Analyst Count
- CMCO 1
- RAPT 8
- Target Price
- CMCO $35.00
- RAPT $46.75
- AVG Volume (30 Days)
- CMCO 287.0K
- RAPT 507.9K
- Earning Date
- CMCO 10-30-2025
- RAPT 11-11-2025
- Dividend Yield
- CMCO 1.76%
- RAPT N/A
- EPS Growth
- CMCO N/A
- RAPT N/A
- EPS
- CMCO N/A
- RAPT N/A
- Revenue
- CMCO $959,221,000.00
- RAPT N/A
- Revenue This Year
- CMCO $3.23
- RAPT N/A
- Revenue Next Year
- CMCO $5.02
- RAPT N/A
- P/E Ratio
- CMCO N/A
- RAPT N/A
- Revenue Growth
- CMCO N/A
- RAPT N/A
- 52 Week Low
- CMCO $11.78
- RAPT $5.67
- 52 Week High
- CMCO $41.05
- RAPT $42.39
- Technical
- Relative Strength Index (RSI)
- CMCO 50.00
- RAPT 61.29
- Support Level
- CMCO $14.51
- RAPT $25.50
- Resistance Level
- CMCO $16.33
- RAPT $42.39
- Average True Range (ATR)
- CMCO 0.77
- RAPT 3.91
- MACD
- CMCO 0.05
- RAPT -0.19
- Stochastic Oscillator
- CMCO 31.79
- RAPT 30.02
About CMCO Columbus McKinnon Corporation
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.